Back
CRISPR Therapeutics AG Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
$51.05
Seasonality Move:
-4.79%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.95 | Sell |
| 20-day SMA: | 55.15 | Sell |
| 50-day SMA: | 54.91 | Sell |
| 200-day SMA: | 53.19 | Buy |
| 8-day EMA: | 11.86 | Buy |
| 20-day EMA: | 5.08 | Buy |
| 50-day EMA: | 2.09 | Buy |
| 200-day EMA: | 0.53 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.26 | Buy |
| Relative Strength Index (14 RSI): | 45.46 | Sell |
| Chaikin Money Flow: | -63712 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.35 - 57.29) | Sell |
| Bollinger Bands (100): | (52.51 - 65.39) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 53.35 while CRSP 8-day simple moving average is 54.95, which is a Sell signal.
-
The stock price of CRSP is 53.35 while CRISPR Therapeutics AG 20-day SMA is 55.15, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 54.91 while CRSP share price is 53.35, making it a Sell technically.
-
CRSP stock price is 53.35 and CRISPR Therapeutics AG 200-day simple moving average is 53.19, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $53.35. The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.9B
Price in USD:
53.35
Share Volume:
1.6M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 53.35 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 53.35 while CRSP 8-day exponential moving average is 11.86, which is a Buy signal.
-
The stock price of CRSP is 53.35 while CRISPR Therapeutics AG 20-day EMA is 5.08, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 2.09 while CRSP share price is 53.35, making it a Buy technically.
-
CRSP stock price is 53.35 and CRISPR Therapeutics AG 200-day simple moving average is 0.53, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.77 per share, and an increase next year of $0.35 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 4.26, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 45.46, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (53.35 - 57.29), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (52.51 - 65.39), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.